The market for new antibiotics is effectively failing. No novel class of drugs for the most virulent and persistent infections, those caused by Gram negative bacteria, has entered the clinic for over 50 years, and the drugs we have are steadily, if slowly, becoming less effective. Earlier this year Dame Sally Davies, the outgoing Chief Medical Officer for England, described the threat of antibiotic resistance as ‘catastrophic’ and potentially as great as that from climate change. Peter Jackson, Executive Director of the AMR Centre in Alderley Park, UK, is among those who believe that…
BI (Business Intelligence) is a set of processes, architectures, and technologies that convert raw data into meaningful information that drives profitable business actions. It is a suite of software and services to transform data into actionable intelligence and knowledge.
• Measurement: creating KPI (Key Performance Indicators) based on historic data • Identify and set benchmarks for varied processes. • With BI systems organizations can identify market trends and spot business problems that need to…
Cambridge Antibody Technology has been described as the ‘jewel in the crown’ of the UK biotech industry; it is certainly one of our region’s principal success stories. This company, originally known as CAT, was founded in 1989 to take advantage of phage display technology for the development of antibody therapeutics. Following worldwide success with the blockbuster anti-TNF antibody adalimumab (Humira™) it was acquired by AstraZeneca in 2006 and now forms part of that company’s biologics subsidiary.
There has been plenty of speculation about the reasons for CAT’s stellar success and how this…
When it comes to influencing prospective customers in the life science sector, outbound marketing approaches such as cold calling, banner ads and unsolicited emails are no longer delivering a return on investment like they used to. Poorly targeted and relatively expensive, these once tried-and-tested tactics are increasingly delivering disappointing results. As marketers, if we want to continue to engage with modern scientific audiences, it’s vital that we adapt to be successful. Here, we look at how buyer behaviour has evolved, and why updating your marketing strategy using an inbound…
Whatsapp, Youtube, Google Ads, Linkedin, Facebook, Instagram, Twitter, e-mail, Teams, Skype, Slack… it’s easy to feel the dread and anxiety when glancing at your phone on an afternoon! All these platforms have one thing in common: your attention!
Even scientific brands have now joined the incessant competition for your attention. So how do you separate the signal from the noise in this increasingly competitive world?
Content Marketing for Life Sciences
We should all be familiar with content marketing, or inbound marketing, by now. These concepts underlie how you are found online in your…
Disaster can strike at any moment, but where do you start to put things right when the worst happens and fire ravages your priceless research, expensive equipment and impacts thousands of your patients who depend on the lab work for life-saving medical treatment?
This was the position Christie NHS Trust found themselves in after the fire that devastated the Patterson building in Manchester in 2017 leaving hundreds of researchers stranded and countless patients at risk. Fortunately, Restore Harrow Green (RHG) who are specialists in Laboratory logistics and ground transportation with experience…
It’s no secret that life science tradeshows can provide an invaluable opportunity to raise your profile and boost awareness of your latest offering. However, these events can also consume substantial amounts of budget – including booth set-up costs, sponsorship fees and travel expenses, not to mention a significant chunk of your team’s time. So, how can you make sure you secure a good return on your investment?
The key to success is to use the event as a platform to engage with life science media, who can help you extend your reach beyond the show itself. With the help of media partners, you…
We are seeing an era of change by the Global regulatory bodies for Pharmaceuticals, Medical devices and in-vitro diagnostics - and companies in the Life Sciences sector are working overtime to understand and adopt this brand new world.
While the companies in the US are facing regulatory headwinds on Patient safety, the EU region is shaking the world with the new MDR and IVDR guidelines.
The overall intent is good but the journey towards bringing this change is going to disrupt a lot of companies in the way.
The main challenges for the Medical device or in-vitro diagnostics companies are:•…
Digital Marketing and Life Sciences are more similar than you might think.
Both are multi-billion dollar industries that use testing and logic to prove hypotheses. Both markets use big data sets, whether it’s recording vast experimental results or simply organising the world’s information online.
The simplest similarity, however, is the enormous growth potential of both SEO and Life Sciences.
Some of the latest innovations in Life Science spaces have made incredible scientific feats commonplace. Nowadays, documenting the human genome is readily available to consumers on a global scale.…
As Inward Investment Manager (Life Sciences) for Invest ESSEX, it gives me enormous pleasure to see Harlow in Essex on everyone’s lips in the industry right now.
Last April in Manchester, the third annual Public Health Research and Science Conference served noticed to the 400 delegates that Public Health England (PHE) was in the process of creating a world-leading campus of excellence for public health research, improvement and protection, and a new headquarters, in Harlow.
Work is now underway with phased occupation beginning in late 2021 with PHE Harlow, as the campus will be titled,…